Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis

This book is a practical and up-to-date review that discusses the impact of traditional cardiovascular risk factors in patients with rheumatoid arthritis, the effect of rheumatoid arthritis disease activity and severity on cardiovascular comorbidity, and the influence of rheumatoid arthritis drug therapy on cardiovascular risk. This title also explores cardiovascular disease as a manifestation of rheumatoid arthritis and highlights the available methods for screening and diagnosing these conditions. Current and emerging therapies to aid clinicians in the daily management of their patients are also featured in this title. Busy healthcare professionals who are looking for a collaborative approach to these conditions will benefit from this comprehensive overview.

A concise, practical pocketbook that provides both cardiologists and rheumatologists with an up-to-date review of the background and advances for these concomitant diseases A comprehensive overview of the current and emerging treatment recommendations for cardiovascular complications in patients with rheumatoid arthritis Includes an evidence-based discussion of clinical approaches for these conditions, including the latest updates on the rheumatoid arthritis-specific cardiovascular disease risk calculator in this emerging treatment sector Easily accessible text, tables, and images illustrate the key concepts discussed in the book Includes supplementary material: sn.pub/extras

Autorentext
Anne Grete Semb, MD, PhD is a senior consultant cardiologist, the founder
and leader of a Preventive Cardio-Rheuma Clinic, the leader of the cardiovascular-rheuma research team at Diakonhjemmet hospital, Oslo, Norway and has 8 PhD students. She is a regular reviewer for several international rheumatology and cardiology journals. She has published more than 200 original scientific publications in peer-reviewed journals, book chapters and conference abstracts. She has led 3 clinical trials/studies, participated in 17 clinical trials/studies, whereas 13 trials/studies have been investigator initiated. She is a member of the European Society of Cardiology (ESC)Working Group of Cardiovascular Pharmacology and Drug Therapy. She is a member of the Eular task force group for Cardiovascular Disease Risk Management in Rheumatic Diseases in 2010 and 2015, one of the founders of and now the administrative leader of the A TransAtlantic Cardiovascular risk Consortium for Rheumatoid Arthritis (ATACC-RA).

Inhalt
Overview of rheumatoid arthritis and mortality in relation to cardiovascular disease.- Non-atherosclerotic cardiac manifestations of rheumatoid arthritis.- Risk factors for cardiovascular disease in rheumatoid arthritis.- Cardiovascular disease risk evaluation.- Pharmacological management of cardiovascular disease in patients with rheumatoid arthritis.- Non-pharmacological interventions for cardiovascular complications in patients with rheumatoid arthritis.- Conclusions.